Skip to Main Content

Paper Details

Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).
J Clin Oncol
22
2022
Author NameAffiliation
Ingrid A MayerVanderbilt University
Eric P WinerDana-Farber Cancer Institute
Lois ShepherdQueen's University
Matthew P GoetzMayo Clinic
Fatima CardosoChampalimaud Clinical Center/Champalimaud Foundation
  • 1 - 5

Datasets

Release 1.2